Literature DB >> 25225433

Responsibility for costs associated with clinical trials.

Paul J Martin1, Nancy Davenport-Ennis2, Nicholas J Petrelli3, F Marc Stewart4, Frederick R Appelbaum4, Al Benson5.   

Abstract

Mesh：

Year:  2014        PMID： 25225433      PMCID： PMC4876354          DOI： 10.1200/JCO.2014.57.1422

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

Authors:  Lowell E Schnipper; Thomas J Smith; Derek Raghavan; Douglas W Blayney; Patricia A Ganz; Therese Marie Mulvey; Dana S Wollins
Journal:  J Clin Oncol       Date:  2012-04-03       Impact factor: 44.544

2.  Effect of the accountable care act of 2010 on clinical trial insurance coverage.

Authors:  Sheetal M Kircher; Al B Benson; Matthew Farber; Halla S Nimeiri
Journal:  J Clin Oncol       Date:  2011-12-27       Impact factor: 44.544

3.  American Society of Clinical Oncology 2013 top five list in oncology.

Authors:  Lowell E Schnipper; Gary H Lyman; Douglas W Blayney; J Russell Hoverman; Derek Raghavan; Dana S Wollins; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2013-10-29       Impact factor: 44.544

4.  Incremental treatment costs in national cancer institute-sponsored clinical trials.

Authors:  Dana P Goldman; Sandra H Berry; Mary S McCabe; Meredith L Kilgore; Arnold L Potosky; Michael L Schoenbaum; Matthias Schonlau; Jane C Weeks; Richard Kaplan; Jose J Escarce
Journal:  JAMA       Date:  2003-06-11       Impact factor: 56.272

5.  The standard of care: legal history and definitions: the bad and good news.

Authors:  Peter Moffett; Gregory Moore
Journal:  West J Emerg Med       Date:  2011-02

6.  Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010).

Authors:  E Liniker; M Harrison; J M J Weaver; N Agrawal; A Chhabra; V Kingshott; S Bailey; T G G Eisen; P G Corrie
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640
  6 in total
  5 in total

1.  Recognizing the Financial Burden of Cancer Patients in Clinical Trials.

Authors:  Ryan D Nipp; Elizabeth Powell; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2015-05-18

2.  The Affordable Care Act and Cancer Care Delivery.

Authors:  Gabriel A Brooks; J Russell Hoverman; Carrie H Colla
Journal:  Cancer J       Date:  2017 May/Jun       Impact factor: 3.360

3.  Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada.

Authors:  P A Tang; A E Hay; C J O'Callaghan; N Mittmann; C R Chambers; J L Pater; N B Leighl
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

4.  Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.

Authors:  Kenneth L Kehl; Cheryl P Fullmer; Siqing Fu; Goldy C George; Kenneth R Hess; Filip Janku; Daniel D Karp; Shumei Kato; Cynthia K Kizer; Razelle Kurzrock; Aung Naing; Shubham Pant; Sarina A Piha-Paul; Vivek Subbiah; Apostolia M Tsimberidou; David S Hong
Journal:  Clin Cancer Res       Date:  2017-07-20       Impact factor: 12.531

5.  Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program.

Authors:  Ryan D Nipp; Hang Lee; Elizabeth Powell; Nicole E Birrer; Emily Poles; Daniel Finkelstein; Karen Winkfield; Sanja Percac-Lima; Bruce Chabner; Beverly Moy
Journal:  Oncologist       Date:  2016-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.